Thank you for that question.
Yes, I think that really would be my top request. I think that within centres, there's a need to support multidisciplinary teams, and we came close to such a mechanism, I think, with the CIHR team grants, but we've lost that. So I think it's very important to see that opportunity resurrected. It's kind of ironic to me in some ways that we're pulling down that capacity at the same time as other countries are building it up.
I also want to emphasize the importance of having collaborations across multiple centres. So something that I think both Michael and I touched on, but maybe didn't emphasize enough, is that while Canada has a very strong track record of individual researchers, we are also regarded as highly collaborative. In fact pharma likes doing studies in Canada because the health care system actually enables cooperation. We're not competing with each other to get patients, so we can enter a lot of people into studies, and we have certain strengths. Some centres have strengths that other centres do not.